← Leaderboards
Judy Sakanari
University Of California, San Francisco
$866,335
Attributed
$2,087,109
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $410K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,087,109 · 2
By mechanism
R01$1,627,699 · 1
R21$459,410 · 1
Top collaborators
- James W Janetka4 shared
- Sara Lustigman4 shared
- Makedonka Mitreva4 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jordan David Ward$3,106,306
Others in their field
Other Emerging Leaders on “Novel Therapeutics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Research focus
Novel TherapeuticsPharmaceutical PreparationsIn VitroNematodaOnchocerciasisParasitesInfectionInternationalIn VivoNeglectOcular OnchocerciasisOnchocercaAffectDeveloping CountriesAdultEvaluationDesignInnovationAnalogDrug TargetingLeadMolecularAnimal ModelPhenotype
Grant awards (6)
Integrative approach for accelerating filarial worm drug discovery to treat river blindness$410,000
R01 · FY2024 · EY
Integrative approach for accelerating filarial worm drug discovery to treat river blindness$410,000
R01 · FY2023 · EY
Integrative approach for accelerating filarial worm drug discovery to treat river blindness$397,700
R01 · FY2022 · EY
Integrative approach for accelerating filarial worm drug discovery to treat river blindness$409,999
R01 · FY2021 · EY
Novel Therapeutics for Treatment of River Blindness and Lymphatic Filariasis$195,658
R21 · FY2018 · AI · contact PI
Novel Therapeutics for Treatment of River Blindness and Lymphatic Filariasis$263,752
R21 · FY2017 · AI · contact PI